Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Social Development and Health Promotion Research Centre, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
J Vasc Nurs. 2024 Sep;42(3):165-176. doi: 10.1016/j.jvn.2024.05.002. Epub 2024 May 31.
To identify the factors associated with thrombosis in dialysis patients.
Thrombosis is a leading cause of vascular access failure in dialysis patients. Numerous risk factors contribute to thrombosis in this population.
A systematic search was conducted across international databases using standardized keywords. The quality of the selected studies was assessed using the STROBE and CONSORT checklists. The findings were summarized in a Garrard table. Meta-analysis was performed using CMA software. The study adhered to the guidelines outlined in the PRISMA statement.
A total of 180 articles were reviewed. The odds ratio for thrombosis in patients with arteriovenous grafts compared to arteriovenous fistulas was 10.93 (95 % CI: 9.35-12.78), demonstrating statistical significance (P = 0.001). Similarly, hemodialysis patients had an odds ratio of thrombosis 3.60 times higher than non-hemodialysis patients (95 % CI: 3.54-4.19), with statistical significance (P = 0.001). Patients undergoing single-stage basilic vein transposition had a 1.89 times higher risk of thrombosis compared to those undergoing two-stage transposition (95 % CI: 1.04-3.46), also demonstrating statistical significance (P = 0.038).
Thrombosis in patients with end-stage renal disease undergoing dialysis was significantly associated with various factors, including graft access, single-stage basilic vein transposition, and hemodialysis. Additional contributing factors to thrombosis included diabetes, elevated homocysteine levels, female gender, age over 50, access location, and low access blood flow velocity. The analysis revealed a higher incidence of thrombosis in end-stage renal disease patients undergoing hemodialysis compared to those not undergoing dialysis, as well as in patients with arteriovenous grafts compared to those with arteriovenous fistulas. These findings underscore the importance of recognizing and managing these risk factors to prevent thrombotic events and enhance patient care within the dialysis setting.
确定与透析患者血栓形成相关的因素。
血栓形成是透析患者血管通路失败的主要原因。该人群中存在许多导致血栓形成的危险因素。
使用标准化关键词对国际数据库进行系统搜索。使用 STROBE 和 CONSORT 清单评估所选研究的质量。研究结果总结在 Garrard 表中。使用 CMA 软件进行荟萃分析。研究遵循 PRISMA 声明中概述的指南。
共审查了 180 篇文章。与动静脉瘘相比,动静脉移植物患者的血栓形成比值比为 10.93(95%CI:9.35-12.78),具有统计学意义(P=0.001)。同样,与非血液透析患者相比,血液透析患者的血栓形成比值比为 3.60 倍(95%CI:3.54-4.19),具有统计学意义(P=0.001)。与两阶段转位相比,单阶段贵要静脉转位患者的血栓形成风险增加 1.89 倍(95%CI:1.04-3.46),也具有统计学意义(P=0.038)。
接受透析的终末期肾病患者的血栓形成与多种因素显著相关,包括移植物通路、单阶段贵要静脉转位和血液透析。血栓形成的其他促成因素包括糖尿病、同型半胱氨酸水平升高、女性、年龄超过 50 岁、通路位置和低通路血流速度。分析表明,与未透析的终末期肾病患者相比,接受血液透析的患者发生血栓形成的发生率更高,与动静脉瘘患者相比,动静脉移植物患者的血栓形成发生率更高。这些发现强调了识别和管理这些危险因素的重要性,以预防血栓形成事件并改善透析环境中的患者护理。